Published on 30 Dec 2023 on Simply Wall St. via Yahoo Finance
Even after rising 4.3% this past week, Amicus Therapeutics (NASDAQ:FOLD) shareholders are still down...
This month, we saw the Amicus Therapeutics, Inc. (NASDAQ:FOLD) up an impressive 32%. But that doesn't change the fact that the returns over the last three years have been less than pleasing. After all, the share price is down 39% in the last three years, significantly under-performing the market.
Although the past week has been more reassuring for shareholders, they're still in the red over the last three years, so let's see if the underlying business has been responsible for the decline.
Check out our latest analysis for Amicus Therapeutics